Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Accounts Payable
Burning Rock Biotech Ltd
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Accounts Payable
¥18.1m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Accounts Payable
¥3.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Accounts Payable
¥372.5m
|
CAGR 3-Years
46%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Accounts Payable
¥299.9m
|
CAGR 3-Years
39%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Accounts Payable
¥13.1B
|
CAGR 3-Years
57%
|
CAGR 5-Years
47%
|
CAGR 10-Years
90%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Accounts Payable
¥19.3m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Accounts Payable?
Accounts Payable
18.1m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Accounts Payable amounts to 18.1m CNY.
What is Burning Rock Biotech Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
2%
Over the last year, the Accounts Payable growth was -65%. The average annual Accounts Payable growth rates for Burning Rock Biotech Ltd have been -20% over the past three years , 2% over the past five years .